John A. Dawson, CBE

John A. Dawson, CBE, is an eminent and widely-respected figure in the healthcare sector who consults for the Vulpes Life Sciences Fund.

As former Chief Executive Officer of Oxford Biomedica, he was recognized for his outstanding leadership in delivering the life-saving Oxford AstraZeneca COVID-19 vaccine with unprecedented speed in 2021. During his 13-year tenure at Oxford Biomedica, the business grew into a global leader in viral vector technologies for cell and gene therapy, resulting in it entering the FTSE 250 index in 2020.

John currently serves as a non-executive director at Ergomed, a specialized provider of services to the pharmaceutical industry, Chinese Speciality Pharma Ltd., a company that brings innovative specialty and rare disease products to China, Norgine, a leading European specialist pharmaceutical company that has been committed to bringing transformative products to patients for over a century, and Virocell, a gene therapy manufacturing company

Prior to his tenure at Oxford Biomedica, John held several senior executive roles, including Managing Director for Europe at Cephalon, Inc., and Financial Director for Serono UK. Mr. Dawson is a Chartered Accountant and holds a BSc in Mathematics from Swansea University.

Contact Us

Tap into Vulpes' wealth of experience and expertise.

Nothing on this website should be construed as an offer to sell or a solicitation of an offer to purchase any investments, securities or products or the giving of any advice in relation to any investments, securities or products in any jurisdiction where such offer or solicitation is not qualified or exempt from registration or permitted by law. The access, use and/or distribution of this website’s information, materials and contents may be restricted by law in certain jurisdictions. It is your sole responsibility to be made aware of and to fully comply with such restrictions.
Vulpes Investment Management Pte. Ltd., and their respective funds, affiliates or subsidiaries does not guarantee the accuracy or completeness of the information, materials and contents on this website and expressly disclaims liability for any errors in, or omissions from, such information, materials and contents or this website in general. Links to other websites from this website are for convenience only. You agree that your access, use and/or distribution of such other websites (including the information, materials and contents therein) is entirely at your own risk and subject to the terms and conditions of access, use and/or distribution contained therein.